Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

February 2016
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Biologics & Biosimilars Congress
01 Feb 2016 - 02 Feb 2016
Berlin, Germany
Biologics & Biosimilars Congress
More information
01 Feb 2016 - 02 Feb 2016
Berlin, Germany
Biosimilars Congress
More information
Cell Culture 2016
02 Feb 2016 - 04 Feb 2016
London, UK
Cell Culture 2016
More information
World ADC Berlin
08 Feb 2016 - 10 Feb 2016
Berlin, Germany
World ADC Berlin
More information
08 Feb 2016 - 09 Feb 2016
Berlin, Germany
2nd Annual Biosimilars Summit
More information
Biosimilar Drug Development World 2016
10 Feb 2016 - 11 Feb 2016
Barcelona, Spain
Biosimilar Drug Development World 2016
More information
Flow Chemistry Europe 2016 - 6th International Congress of the Flow Chemistry Society
16 Feb 2016 - 18 Feb 2016
Cambridge, UK
Flow Chemistry Europe 2016 - 6th International Congress of the Flow Chemistry Society
More information
Downstream Processing World Congress 2016
23 Feb 2016 - 24 Feb 2016
Munich, Germany
Downstream Processing World Congress 2016
More information
8th Annual AsiaTIDES
24 Feb 2016 - 26 Feb 2016
Kyoto, Japan
8th Annual AsiaTIDES
More information
<< 1 2 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!